• Je něco špatně v tomto záznamu ?

Immunomodulatory role of prolactin in diabetes development

P Cejkova, M Fojtikova, M Cerna

. 2009 ; 9 (1) : 23-27.

Jazyk angličtina Země Nizozemsko

Typ dokumentu práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12008393

Pituitary hormone and cytokine prolactin (PRL) is one of the mediators of the bidirectional communication between neuroendocrine and immune systems. It participates in many immunomodulatory activities, affects differentiation and maturation of both, B and T lymphocytes and enhances inflammatory responses and production of immunoglobulins. Hyperprolactinemia has been described in many autoimmune diseases, both systemic (SLE, RA, PsA) and organ-specific (T1D, CD and others) and the activity of PRL has been intensively studied. Nevertheless, no data on PRL contribution to pathogenesis of diabetes mellitus is available, although the effect of PRL on beta cells of the pancreas and insulin secretion has been observed.

Bibliografie atd.

Literatura.

000      
02682naa a2200505 a 4500
001      
bmc12008393
003      
CZ-PrNML
005      
20130102124104.0
008      
120315s2009 ne eng||
009      
AR
040    __
$a ABA008 $b cze $d ABA008
041    0_
$a eng
044    __
$a ne
100    1_
$a Daňková, Pavlína $7 xx0146621 $u Institute of General Biology and Genetics, Third Faculty of Medicine, Charles University in Prague, Ruska 87, 10000 Prague 10, Czech Republic. Pavlina.Cejkova@lf3.cuni.cz
245    10
$a Immunomodulatory role of prolactin in diabetes development / $c P Cejkova, M Fojtikova, M Cerna
504    __
$a Literatura. $b 40
520    9_
$a Pituitary hormone and cytokine prolactin (PRL) is one of the mediators of the bidirectional communication between neuroendocrine and immune systems. It participates in many immunomodulatory activities, affects differentiation and maturation of both, B and T lymphocytes and enhances inflammatory responses and production of immunoglobulins. Hyperprolactinemia has been described in many autoimmune diseases, both systemic (SLE, RA, PsA) and organ-specific (T1D, CD and others) and the activity of PRL has been intensively studied. Nevertheless, no data on PRL contribution to pathogenesis of diabetes mellitus is available, although the effect of PRL on beta cells of the pancreas and insulin secretion has been observed.
590    __
$a bohemika - dle Pubmed
650    02
$a protilátky $x imunologie $x metabolismus $7 D000906
650    02
$a B-lymfocyty $x imunologie $x metabolismus $x patologie $7 D001402
650    02
$a buněčná diferenciace $7 D002454
650    02
$a diabetes mellitus $x imunologie $x metabolismus $7 D003920
650    02
$a lidé $7 D006801
650    02
$a hyperprolaktinemie $x metabolismus $7 D006966
650    02
$a mediátory zánětu $x imunologie $x metabolismus $7 D018836
650    02
$a inzulin $x sekrece $7 D007328
650    02
$a beta-buňky $x imunologie $x metabolismus $x patologie $7 D050417
650    02
$a neuroimunomodulace $7 D015213
650    02
$a prolaktin $x imunologie $x metabolismus $7 D011388
650    02
$a T-lymfocyty $x imunologie $x metabolismus $x patologie $7 D013601
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Hušáková, Markéta, $7 xx0143346 $d 1977-
700    1_
$a Černá, Marie, $d 1964- $7 mzk2004258459
773    0_
$t Autoimmunity Reviews $p Autoimmun Rev $g Roč. 9, č. 1 (2009), s. 23-27 $w MED00008572 $x 1568-9972
910    __
$a ABA008 $b x $y 4
990    __
$a 20120319124424 $b ABA008
991    __
$a 20130102124202 $b ABA008
999    __
$a ok $b bmc $g 901851 $s 765284
BAS    __
$a 3
BMC    __
$a 2009 $b 9 $c 1 $d 23-27 $m Autoimmunity reviews $x MED00008572 $i 1568-9972 $n Autoimmun Rev
LZP    __
$a 2012-1Q10/jt

Najít záznam

Citační ukazatele

Možnosti archivace